엑셀세라퓨틱스
1,059KRWMarket close of 10/20 (Tue)
Down -3.29%-36KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)1,050KRWDown -0.85%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 1,095
- High
- 1,095
- Low
- 1,059
- Day range
- Day range low 1,059 high 1,095, open 1,095, close 1,059, previous close 1,095
- Volume
- 3×10K shares
- 34.57 million KRW 0.42× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
5%5% of the way up from the lowest close in 1 year (252 sessions) · -60.3% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-11.2B KRWOperating income over the last four quarters -11.2B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move-3.29%usual range
- Trading value0.4×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue1.0B KRW
- vs. year ago
- +209.8%
- vs. prior quarter
- -3.9%
- Operating income-2.9B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-285.2%
- vs. year ago
- +490.6 pp
- vs. prior quarter
- +21.0 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.